Nonalcoholic Steatohepatitis and Hepatic Fibrosis in HIV-1-Monoinfected Adults With Elevated Aminotransferase Levels on Antiretroviral Therapy.
about
Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study.Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection.Liver test abnormalities in patients with HIV mono-infection: assessment with simple noninvasive fibrosis markersGenetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART).Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study.Transient elastography for the detection of hepatic fibrosis in HIV-monoinfected adults with elevated aminotransferases on antiretroviral therapyPrevalence of and progression to abnormal noninvasive markers of liver disease (aspartate aminotransferase-to-platelet ratio index and Fibrosis-4) among US HIV-infected youth.Novel Approaches to Targeting Visceral and Hepatic Adiposities in HIV-Associated Lipodystrophy.Simtuzumab treatment of advanced liver fibrosis in HIV and HCV-infected adults: results of a 6-month open-label safety trial.PNPLA3 polymorphism increases risk for and severity of chronic hepatitis C liver disease.Adverse effects of antiretroviral therapy on liver hepatocytes and endothelium in HIV patients: An ultrastructural perspective.HIV-1 viral protein R (Vpr) induces fatty liver in mice via LXRα and PPARα dysregulation: implications for HIV-specific pathogenesis of NAFLD.Screening for nonalcoholic steatohepatitis by using cytokeratin 18 and transient elastography in HIV mono-infection.The Fat of the Matter: Obesity and Visceral Adiposity in Treated HIV Infection.Nevirapine-induced liver lipid-SER inclusions and other ultrastructural aberrations.A Review of Long-Term Toxicity of Antiretroviral Treatment Regimens and Implications for an Aging Population.NAFLD and HIV: Do Sex, Race, and Ethnicity Explain HIV-Related Risk?Human immunodeficiency virus and liver disease: A comprehensive update.Adiponectin and the steatosis marker Chi3L1 decrease following switch to raltegravir compared to continued PI/NNRTI-based antiretroviral therapy.Predictive factors associated with liver fibrosis and steatosis by transient elastography in patients with HIV mono-infection under long-term combined antiretroviral therapyInsulin Resistance in HIV-Patients: Causes and Consequences
P2860
Q31050092-60707E88-AB99-46E3-AD8C-EE4BBD39895CQ31149395-093C2D45-9CDF-4D4C-A169-6941564CC013Q33621724-61ACA893-E301-49AF-9D6D-474003F2DC14Q33778556-332C4657-F0E6-48E5-AF70-721301A3CEBFQ33787655-D668D949-E070-4CC9-AB29-5707A6F8742EQ36263389-E2E02CC0-4A4F-46CB-975A-FFDC663C66ACQ36671995-312555F1-E450-4D7D-B025-9DB9C4051188Q38614025-096CBB7E-E661-4E56-9220-7EDC0F853D38Q38861564-871D0E30-F8A5-4FAD-A0AC-2D53E9079713Q39041976-4AECE797-65DE-4096-99C1-2D6C0EC0B22BQ40300348-AF102D47-5999-4DD4-89A5-0E673E9BA94DQ42657454-55A207D8-5321-43C6-B11B-E933685F308BQ47547885-3B70BF24-5CC6-4146-8A68-8DCDBD29C852Q47891372-46DAC65E-FD37-4845-B7DE-3079292DA936Q50101970-D030DAA5-903F-44BF-A2DD-BD619FA2C5ACQ54211761-1B26EF15-B15E-4D33-B7CD-6D664E42A4B8Q54232638-0EA8085B-9750-4D59-BA3C-54BD224AC10EQ55109199-8E634522-EA31-410A-8A52-FAA62A1FA19EQ55238731-4E196FF2-6F66-47DE-A568-7AE013089941Q58560381-D860C2AC-D066-4EE0-AEEE-D10764586E79Q58763014-87354B62-6EDA-4F2F-A115-2749D3E0AAF9
P2860
Nonalcoholic Steatohepatitis and Hepatic Fibrosis in HIV-1-Monoinfected Adults With Elevated Aminotransferase Levels on Antiretroviral Therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Nonalcoholic Steatohepatitis a ...... els on Antiretroviral Therapy.
@ast
Nonalcoholic Steatohepatitis a ...... els on Antiretroviral Therapy.
@en
type
label
Nonalcoholic Steatohepatitis a ...... els on Antiretroviral Therapy.
@ast
Nonalcoholic Steatohepatitis a ...... els on Antiretroviral Therapy.
@en
prefLabel
Nonalcoholic Steatohepatitis a ...... els on Antiretroviral Therapy.
@ast
Nonalcoholic Steatohepatitis a ...... els on Antiretroviral Therapy.
@en
P2093
P2860
P50
P356
P1476
Nonalcoholic Steatohepatitis a ...... els on Antiretroviral Therapy.
@en
P2093
Abigail Orenstein
Colleen Hadigan
Francine Thomas
Joseph A Kovacs
Lindsay Matthews
Mary McLaughlin
Michael Proschan
Mones Abu-Asab
Richard Lempicki
Ronald E Engle
P2860
P304
P356
10.1093/CID/CIV101
P407
P577
2015-02-13T00:00:00Z